JP Morgan Chase’s Symmetry Medical SMA Stock Holding History
Bought
Maintained
Sold
JP Morgan Chase's SMA Position: Q4 2014 in Review
JP Morgan Chase sold out of Symmetry Medical (SMA) in Q4 2014, closing a stake of 575,850 shares — an estimated $5.81M sold.
JP Morgan Chase first reported a position in SMA in Q2 2013 and held it in 6 quarters. The position peaked at $5.81M in Q3 2014. 0 funds tracked by Wall St. Rank hold SMA as of Q4 2014.
- JP Morgan Chase reported no remaining Symmetry Medical position as of Q4 2014 after selling out during the quarter.
- JP Morgan Chase sold 575,850 Symmetry Medical shares in Q4 2014, an estimated $5.81M.
- JP Morgan Chase first reported a position in Symmetry Medical in Q2 2013 and held it in 6 quarters.
- JP Morgan Chase's Symmetry Medical position peaked at $5.81M in Q3 2014.
- 0 funds tracked by Wall St. Rank held Symmetry Medical as of Q4 2014.
Based on JP Morgan Chase's 13F filing for Q4 2014, filed 13 Feb 2015.